Table 2.
Experimental Model | TRPV1 Modulation | Effects of TRPV1 on Major Study Endpoints | Role of TRPV1 Activation | Reference | |
---|---|---|---|---|---|
AMI + sensory desensitization | farm pig high dose capsaicin |
↓ | decreased infarct size and increased CGRP level | beneficial | [42] |
in vivo rat neonatal capsaicin treatment |
↓ | decreased infarct | beneficial | [77] | |
Ischemia reperfusion injury | H9C2 cell, capsazepine or TRPV1 siRNA |
↓ | decreased cell viability | detrimental | [79] |
ex vivo TRPV1 KO mouse |
↓ | decreased infarct size | beneficial | [80] | |
ex vivo TRPV1 KO mouse, capsazepine |
↓ | improved systolic and diastolic functions | beneficial | [81] | |
in vivo rat Lentivirus-mediated spinal NGF gene knockdown-induced TRPV1 downregulation |
↓ | increased infarct size | detrimental | [84] | |
in vivo rat Lentivirus-mediated spinal NGF gene knockdown-induced TRPV1 downregulation or capsazepine induced TRPV1 inhibition |
↓ | increased infarct size | detrimental | [85] | |
ex vivo diabetic mouse Adenovirus-mediated NGF gene delivery induced TRPV1 upregulation |
↑ | Elevated cardiac CGRP level and improved systolic and diastolic functions | beneficial | [86] | |
Sitagliptin-induced cardioprotection | ex vivo rat AMI, capsazepine and co-administration of sitagliptin |
↓ | capsazepine abolished infarct size limiting effects of sitagliptin | beneficial | [87] |
Morphine-induced cardioprotection | in vivo rat AMI, capsazepine or P5 |
↓ | decreased infarct size | beneficial | [88] |
Early or delayed preconditioning | in vivo/ex vivo rat AMI high dose capsaicin |
↓ | abolished preconditioning-induced cardioprotection | beneficial | [91,92,93,94] |
Pacing-induced preconditioning | ex vivo rat AMI | ↓ | abolished preconditioning-induced cardioprotection | beneficial | [40] |
Remote ischemic preconditioning | in vivo rat AMI, RIPC induced TRPV1 upregulation |
↑ | decreased infarct size | beneficial | [95] |
Remote ischemic postconditioning | in vivo rat AMI, capsazepine |
↓ | decreased infarct size | beneficial | [96] |
Ischemic postconditioning | type 1 diabetic rat ex vivo AMI, capsazepine |
↓ | abolished IPost-induced cardioprotection | beneficial | [97] |